InflaRx vs Shaperon
InflaRx
Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory diseases
46 employees · est. 2007 · Jena, Germany
InflaRx is the older company (2007 vs 2008).
4 signals in the last 90 days
Side-by-Side Comparison
| Metric | InflaRx | Shaperon |
|---|---|---|
| Founded | ||
| Founded | 2007 older | 2008 |
| Headquarters | ||
| Headquarters | Jena, Germany | Seoul, Korea South |
| Employees | ||
| Employees | 46 | 23 |
| Industry | ||
| Industry | Health Care, Health and Wellness, Pharmaceutical | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Series C |
| Total Funding | ||
| Total Funding | $250.20M | $26.00B |
| Funding Rounds | ||
| Funding Rounds | 9 | 1 |
| Services | ||
| Services | Development of anti-C5a and C5aR inhibitors, Clinical trials for inflammatory diseases, Research and development of transformative treatments, Commercialization of complement system inhibitors | Not tracked yet |
| Target Customers | ||
| Target Customers | Hospitals treating COVID-19 patients, Healthcare providers, Pharmaceutical industries, Investors in biotechnology | Not tracked yet |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalAnti-Inflammatory TherapeuticsAnti-C5a TechnologyMonoclonal Antibody DevelopmentChronic Inflammatory DiseasesComplement Activation Inhibitors +8 | ImmunologyInflammasome InhibitorsClinical Stage BiotechNovel ModalityNanobodiesAnti-viral +9 |
| Website | ||
| Website | inflarx.de | shaperon.com |
About InflaRx
InflaRx, founded in 2007, is a Germany-based biopharmaceutical company recognized for pioneering anti-inflammatory therapeutics. The company's slogan, "Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory diseases," clearly reflects its mission. At the core...
About Shaperon
Shaperon is a clinical stage biotech company with a focus on developing novel inflammasome inhibitors (small molecule). Their unique mechanism of action of GPCR-regulated P2X7 inhibition suppresses a broad spectrum of inflammatory cytokines, including IL-1β, IL-18, IL-6, and TNF-α, by controlling bo...
Also comparing in this category
Comparing more than these two?
Get InflaRx, Shaperon and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does InflaRx compare?
A PDF of InflaRx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare InflaRx with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at InflaRx on 14 May 2026, and Shaperon on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
